MetLife Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$116K Buy
6,703
+117
+2% +$2.03K ﹤0.01% 2462
2025
Q1
$144K Buy
6,586
+150
+2% +$3.28K ﹤0.01% 2368
2024
Q4
$205K Sell
6,436
-146
-2% -$4.66K ﹤0.01% 2289
2024
Q3
$190K Sell
6,582
-129
-2% -$3.72K ﹤0.01% 2316
2024
Q2
$257K Buy
6,711
+565
+9% +$21.7K ﹤0.01% 2089
2024
Q1
$361K Buy
6,146
+19
+0.3% +$1.12K ﹤0.01% 1853
2023
Q4
$367K Sell
6,127
-1
-0% -$60 ﹤0.01% 1871
2023
Q3
$233K Buy
6,128
+2
+0% +$76 ﹤0.01% 2116
2023
Q2
$558K Sell
6,126
-42,949
-88% -$3.91M ﹤0.01% 1625
2023
Q1
$3.24M Sell
49,075
-590
-1% -$38.9K 0.02% 701
2022
Q4
$2.57M Hold
49,665
0.02% 792
2022
Q3
$3.39M Buy
49,665
+2,428
+5% +$166K 0.03% 622
2022
Q2
$2.14M Buy
47,237
+5,944
+14% +$269K 0.02% 879
2022
Q1
$2.1M Buy
41,293
+16,567
+67% +$842K 0.01% 972
2021
Q4
$1.17M Buy
24,726
+527
+2% +$24.9K 0.01% 1067
2021
Q3
$798K Hold
24,199
0.01% 1251
2021
Q2
$1.53M Hold
24,199
0.01% 973
2021
Q1
$1.04M Hold
24,199
0.01% 1139
2020
Q4
$1.38M Sell
24,199
-2,552
-10% -$146K 0.01% 990
2020
Q3
$807K Hold
26,751
0.01% 1137
2020
Q2
$874K Buy
26,751
+1,387
+5% +$45.3K 0.01% 1088
2020
Q1
$680K Buy
25,364
+3,069
+14% +$82.2K 0.01% 1062
2019
Q4
$683K Hold
22,295
0.01% 1288
2019
Q3
$537K Hold
22,295
0.01% 1382
2019
Q2
$565K Buy
22,295
+4,997
+29% +$127K 0.01% 1405
2019
Q1
$337K Hold
17,298
﹤0.01% 1687
2018
Q4
$228K Hold
17,298
﹤0.01% 1832
2018
Q3
$308K Buy
+17,298
New +$308K ﹤0.01% 1846
2018
Q2
Sell
-5,716
Closed -$126K 2167
2018
Q1
$126K Buy
+5,716
New +$126K ﹤0.01% 2116